Detalhe da pesquisa
1.
Ursodeoxycholic Acid Treatment-Induced GLOBE Score Changes Are Associated With Liver Transplantation-Free Survival in Patients With Primary Biliary Cholangitis.
Am J Gastroenterol
; 118(7): 1196-1203, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36621963
2.
Major Hepatic Complications in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis: Risk Factors and Time Trends in Incidence and Outcome.
Am J Gastroenterol
; 113(2): 254-264, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29231188
3.
Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy.
Gastroenterology
; 149(7): 1804-1812.e4, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26261009
4.
Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study.
Gastroenterology
; 147(6): 1338-49.e5; quiz e15, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25160979
5.
Liver transplant-free survival according to alkaline phosphatase and GLOBE score in patients with primary biliary cholangitis treated with ursodeoxycholic acid.
Aliment Pharmacol Ther
; 56(9): 1408-1418, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36138566